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Scale (MARS-5), valid and reliable instruments, amongst other questions. The
TSQM yields scores on effectiveness, side-effects, convenience, and global satis-
faction domains. Non-adherence was defined as a score of24 and adherence as a
score of 25 on MARS-5. Multivariate logistic regression and multivariable linear
regression were performed to identify patient characteristics (age, gender, number
of medications, severity, and hypertension drug class) and self-reported reasons
associated with non-adherence and treatment satisfaction.RESULTS:Between No-
vember 2011 and June 2012, 556 MediGuard.org members completed a survey re-
lated to an ACE or ARB: ACE358 (64.4%), ARB198 (35.6%). Patients had mean age
of 62.4 (SD:10.5) years (ACE61.7 years, ARB63.6 years) and 56.3% were female
(ACE58.1%, ARB53.1%). Overall, 51.5% reported medication non-adherence. The
mean TSQM score on effectiveness was 70.4(19.3), side-effects was 95.6(13.8), con-
venience was 84.6(14.0), and global satisfaction was 67.4(19.2). Forgetting, don’t like
to take pills/give injection, and gender were significantly associated with non-
adherence (p0.05). Age, gender, and don’t like to take pills/give injection were
significantly associated with effectiveness, side-effects, and convenience domain
(p0.05), respectively. Age and don’t like to take pills/give injection were signifi-
cantly associated with global satisfaction (p0.05). CONCLUSIONS: In addition to
patient characteristics, patient preferences are important to potentially improve
adherence and satisfaction to hypertension medications.
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OBJECTIVES: To identify multi-attribute utility (MAU) values associated with ve-
nous thromboembolism (VTE) events and to select values for use in economic
models. METHODS: A systematic review of the literature was conducted including
database searches and hand-searching of relevant studies. The database search
included utility studies or RCTs reporting utility scores. The disease area and pop-
ulation were restricted to VTE and adults, respectively. All identified economic
evaluations were hand-searched in order to explore utilities from different eco-
nomic evaluations. Utility sources from three previously developed economic
models for rivaroxaban were also explored. Studies reporting the 8 SF-36 compo-
nents were transformed to EQ-5D using a mapping model outlined by Ara and
Brazier (2008). RESULTS: The database search identified 576 citations, of which 20
studies were included in the review. The hand-search identified 1 study. Two ad-
ditional studies were identified from the economic models, giving a total of 23
studies. Of the 23 studies, 2 studies reported MAUs; 7 studies used direct preference
based measures such as the time trade off technique and the remaining 14 studies
used non-preference based measures such as SF-36. Of the 14 non-preference
based measures, 5 reported mean SF-36 scores for all components and were trans-
formed to EQ-5D. A total of 50 utility values were extracted from the studies. The
selection process identified the following utility scores: 0.62 for DVT, 0.63 for PE and
0.7855 for VTE long-term complications. CONCLUSIONS: There was a large varia-
tion in the extracted utilities (0.04-0.992). Long-term disutility has greater influence
than acute. Cost-utility analyses should model the relationship between acute VTE
events and long-term disutility to capture all health related quality of life impair-
ment.
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OBJECTIVES: To solve problems with recall and aggregation bias in the measure-
ment of utilities it was suggested to determine experienced health moment-by-
moment using the Experience Sampling Method (ESM). This study describes a first
test of feasibility and validity. METHODS: In total 160 persons were included (4
groups with N40; tinnitus, anxiety/depression, atherosclerosis, general public).
ESM data (including health, mood and contextual factors) were collected electron-
ically for six days using a beep questionnaire (10 random times a day) and an
end-of-day questionnaire. In the beep questionnaire a beep-VAS, anchored as the
EQ-5D VAS, was included. In the end-of-day questionnaire the EQ-5D items were
also included, and used to calculate EoD-Utility. Directly before and after the ESM-
period the EQ-5D and Hospital Anxiety and Depression Scale (HADS) were admin-
istered, and used to calculate Before and After utility and VAS scores. Feasibility,
subjective data and convergent validity of ESM, and differences between scores
were analyzed. The relation between beep-VAS, health and mood at beep level
were determined with multilevel analyses. RESULTS: All participants completed
the ESM period and before and after questionnaires. Correlation between beep data
(mean per day) and EoD reports are high for well-being (r.836) and feeling sick
(r.737). Correlations between beep anxiety/depression and the HADS scores are
high (r.627;r.565). In the tinnitus and general public groups, the aggregated
beep-VAS scores (0.65;0.82) are lower than the Before-VAS scores (0.68;0.89) and
After-VAS scores (0.71;0.91). The aggregated EoD-Utility scores (0.80;0.95) are not
different from the After-Utility scores (0.79;0.96). However, in the tinnitus group the
EoD-utility score (0.80) is higher than the Before-Utility score (0.74). Results of the
other groups, and multilevel analyses will be presented at the conference.
CONCLUSIONS: Feasibility and validity of ESM were satisfactory. Health state
scores obtained moment-by-moment using ESM differ from the scores obtained by
using the traditional approach.
PCV90
A NOVEL CONCEPTUAL MODEL OF CAREGIVER BURDEN IN CHRONIC HEART
FAILURE: A QUALITATIVE STUDY
Blackburn S1, Humphrey L1, Maguire L1, Deschaseaux C2, Stromberg A3
1Adelphi Values, Bollington, Cheshire, UK, 2Novartis Pharma, Basel, Switzerland, 3Linköping
University, Linkoping, Sweden
OBJECTIVES: To develop a conceptual model that captures the types of burden and
associated impacts experienced by chronic heart failure (CHF) caregivers.
METHODS: Qualitative interviews were conducted with 24 adult CHF caregivers
from 2 US cities. The 60-minute interviews involved exploratory questions about
the CHF caregiving experience and its impact on caregivers’ quality of life. Data
were analyzed based on Grounded Theory methods. RESULTS: Caregivers were
5311 years, 67% female, 33% non-Caucasian, 37% children of the CHF patients,
17% patient’s spouse and 63% resided with the CHF patient. Qualitative analysis
indicated 4 domains of caregiver burden: (1) physical burdens included tiredness,
health deterioration, physical effort, lack of sleep; (2) emotional/psychological burdens
included feeling overly depended on, worried, guilty, mentally drained, stressed, a
loss of independence, sadness, and feeling overwhelmed; (3) social burdens included
spending less time with family and friends and the decline in the quality of those
relationships, as well as impact on sexual relationships, (4) impact on caregivers’
lifestyles included a lack of time for themselves and non-caregiving tasks, changing
plans, having to stay near to the patient, and the impact at work and on the care-
giver-patient relationship. Many external factors were also described by the care-
givers as impacting the level of burden, such as the patient’s health status or mood,
the volume of the caregivers’ tasks and the level of support from others. This data
has been captured in a conceptual model of CHF caregiver burden. CONCLUSIONS:
The burdens placed on CHF caregivers are multifaceted. The understanding of
these burdens within a valid conceptual model will allow the development of in-
struments to measure the level of CHF caregiver burden. Further research is re-
quired to understand and quantify the link between CHF patients’ symptomology
and the level of burden that this places on caregivers.
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OBJECTIVES: To assess the impact of symptoms in patients with Atrial Fibrilation
(AF) through AF-QoL, a specific questionnaire to measure Health Related Quality of
Life (HRQoL). METHODS: Observational cross-sectional study in cardiologist set-
ting. Patients included were18 years old with paroxystic AF (AFPar) or persistent
AF (AFPer). Main clinical variables: type of AF, NYHA functional stage, symptoms
frequency and duration and CHADS2 index. AF-QoL has 18 items and 3 domains:
psychological, physical and sexual activity, and scores standardized between 0
(worst HRQoL) and 100 (best HRQoL). RESULTS: A total of 824 patients were in-
cluded: 513 (62.3%) with AFPar and 311 (37.7%) with AFPer. 56.1% were male and
mean (SD) age was 68.2 (11.3) years. Patients with AFPar were younger than AFPer
(p0.001). 82.8% and 26.1% of patients with AFPar had palpitations and dyspnea vs.
62.4% and 44.7% of AFPer (p0.001). AFPar was associated to higher thromboem-
bolism risk by CHADS2 (p0.001). Global mean (SD) score for AF-QoL was similar
between both types of AF: 51.23 (23.76) in AFPar and 46.68 (24.48) in AFPer, but
differences were observed in physical domain having AFPar a higher mean score
that AFPer (p0.003). Multivariate analysis showed that being male, having pres-
ence of mild or no symptoms, practicing exercise, having NYHA stage I and II and
not having emergency visits was related with higher score of HRQoL (R20.32;
p0.0001). CONCLUSIONS: AF symptoms have a high impact in HRQoL of patient.
Therapies able to reduce severity of symptoms and number of emergency visits
will have a positive impact on HRQoL in patients with AF.
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OBJECTIVES: The Cambridge Pulmonary Hypertension Outcome Review (CAM-
PHOR) and the Medical Outcomes Study Short Form 36 (SF-36) are widely used to
assess outcome in pulmonary hypertension (PH) patients. The CAMPHOR is a PH-
specific measure consisting of three scales; symptoms, activity limitations and
needs-based QoL. The SF-36 is a generic health status questionnaire consisting of
36 items and eight domains. The aim of this study was to compare the psychomet-
ric properties of these two measures in a population with PH. METHODS: Partici-
pants were recruited from six specialist PH centres in Australia and New Zealand.
They completed the CAMPHOR and SF-36 at two time points, two weeks apart. The
questionnaires were assessed for distributional properties (% scoring minimum
and % scoring maximum), internal consistency (Cronbach’s alpha), test-retest re-
liability (minimum required correlation coefficient  0.85) and construct validity
(CAMPHOR scores by WHO functional classification). RESULTS: The sample com-
prised 65 participants (mean (SD): age 57.2 (14.5) years; male n (%): 14 (21.5)). Most
of the participants were in WHO functional class II (27.7%) or III (61.5%). A high
proportion of participants recorded the maximum score for the SF-36 social func-
tioning (21.3%) and role emotional (25.0%) domains, signifying insensitivity. Test-
retest reliability was below the required level for six of the eight SF-36 domains,
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